Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partner Organizations
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
    • CCAS Member Application
      • Online Membership Application
      • Printable Membership Application
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • Research Updates
    • CCAS Research Award
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
    • Grant Opportunities
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

QOW 414

Authors: Christopher Busack MD, Chinwe Unegbu MD, and Daniela Perez-Velasco DO – Children’s National Hospital


A 3-month-old female patient presents with failure to thrive. Echocardiography reveals severe LV dysfunction, severe mitral regurgitation, and an anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA).Which operative intervention MOST LIKELY reduces the risk of in-hospital death in patients undergoing surgical repair of ALCAPA?

Correct! Wrong!

EXPLANATION


Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) comprises less than 1% of congenital heart defects. There are two clinical phenotypes: (1) infants with an absence of adequate collateral circulation from the right coronary artery (RCA) to the left side of the heart who typically present with severe heart failure symptoms within the first few months of life and (2) patients with adequate collateral supply who remain asymptomatic until adolescence or adulthood. However, patients with collateral supply remain at risk for sudden cardiac death and may present with chest pain or dyspnea on exertion. Without surgical intervention, the mortality exceeds 90% at this time. However, with surgery and current advances, the mortality at the time of ALCAPA repair is less than 10%. Echocardiography is the mainstay of diagnosis but CT angiography or magnetic resonance imaging with 3D reconstruction can be helpful. Angiography is rarely indicated except in special situations.


Although mitral regurgitation (MR) is commonly associated with ALCAPA, there is no consensus as to whether it should be surgically corrected at the time of primary repair. Obviously, correction would add ischemia time to an already severely compromised ventricle. In most cases, MR improves without intervention after surgery to correct ALCAPA alone due to improved ventricular function and reduced end-diastolic volume. However, MR persists in some cases and may require intervention later. Several recent studies indicate that repair of severe MR at the time of initial surgery can be achieved with low risk, improved outcomes, and a reduced need for reoperation. These data support a selective surgical approach for significant MR at the time of ALCAPA surgery, perhaps focusing on cases with structural defects unlikely to change with improvement in myocardial function or regression of ventricular dilation. Neither prophylactic ventricular assist device insertion nor pulmonary arterioplasty at the time of ALCAPA repair reduce the risk of in-hospital death.


REFERENCES


1. Thomas AS, Chan A, Alsoufi B, Vinocur JM, Kochilas L. Long-term Outcomes of Children Operated on for Anomalous Left Coronary Artery From the Pulmonary Artery. Ann Thorac Surg. 2022;113(4):1223-1230. doi: 10.1016/j.athoracsur.2021.07.053.


2. Yu J, Ren Q, Liu X, et al. Anomalous left coronary artery from the pulmonary artery: Outcomes and management of mitral valve. Front Cardiovasc Med. 2022;9:953420. doi: 10.3389/fcvm.2022.953420.


3. Weixler VHM, Zurakowski D, Baird CW, et al. Do patients with anomalous origin of the left coronary artery benefit from an early repair of the mitral valve? Eur J Cardiothorac Surg. 2020;57(1):72-77. doi: 10.1093/ejcts/ezz158.


Poll of the Month

May 2023
In your current practice, do you nasally intubate patients palliated with a Fontan who are on aspirin or other anticoagulants for dental rehabilitation procedures?
View Results
Total Answers 127
Total Votes 127

Upcoming Meeting Information

CCAS 2024 Annual Meeting
April 11, 2024
Anaheim Marriott
Anaheim, CA

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2020 The Congenital Cardiac Anesthesia Society | View Privacy Policy